Trial for Bundibugyo Ebola treatment starts in DRC, WHO says
The World Health Organization has launched a clinical trial in the Democratic Republic of Congo to test new treatments for the Bundibugyo strain of Ebola. Despite progress in testing and treatment capacity, the effort faces significant hurdles due to regional violence and public mistrust.
Why it matters
This trial represents a critical step in addressing a deadly epidemic that currently lacks approved medical interventions, highlighting the intersection of global health and regional security.
A treatment trial for the Bundibugyo Ebola outbreak in the Democratic Republic of Congo enrolled its first patient on Thursday, July 2, 2026, marking a milestone in efforts to combat the epidemic, World Health Organization chief Tedros Adhanom Ghebreyesus told reporters.
The article reports on WHO statements and clinical trial data in a factual, objective manner without loaded language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in